Roche LightCycler 480 PCR System to be used at Koch Institute for advanced cancer research

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the David H. Koch Institute for Integrative Cancer Research at MIT will be using the Roche LightCycler® 480 System, a real-time polymerase chain reaction (PCR) system for the analysis of gene expression and genetic variation, in advanced cancer research.

The Koch Institute plans to use the LightCycler 480 System to support several key areas of research it has identified as being critical for rapid progress toward controlling cancer, such as exploring the molecular and cellular basis of metastasis and engineering the immune system to fight cancer.  The Institute is affiliated with the Massachusetts Institute of Technology in Cambridge, Mass.

"Our approach at MIT offers a unique collaboration between scientists and engineers, which has helped place us at the forefront of the fight against cancer," said Robert Urban, executive director of the Koch Institute. "The LightCycler instruments will provide the platform to help us take advantage of the many applications for real-time PCR technology in cancer research."

The LightCycler 480 System is a fully integrated, 96-well and 384-well plate-based real-time PCR platform for the qualitative and quantitative detection of nucleic acids. It can be used in a broad range of applications in research fields, such as gene expression studies, discovery and analysis of genetic variation, or array data validation.

Source:

Roche Diagnostics

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Roche Diagnostics Limited. (2019, June 18). Roche LightCycler 480 PCR System to be used at Koch Institute for advanced cancer research. News-Medical. Retrieved on December 05, 2020 from https://www.news-medical.net/news/20110407/Roche-LightCycler-480-PCR-System-to-be-used-at-Koch-Institute-for-advanced-cancer-research.aspx.

  • MLA

    Roche Diagnostics Limited. "Roche LightCycler 480 PCR System to be used at Koch Institute for advanced cancer research". News-Medical. 05 December 2020. <https://www.news-medical.net/news/20110407/Roche-LightCycler-480-PCR-System-to-be-used-at-Koch-Institute-for-advanced-cancer-research.aspx>.

  • Chicago

    Roche Diagnostics Limited. "Roche LightCycler 480 PCR System to be used at Koch Institute for advanced cancer research". News-Medical. https://www.news-medical.net/news/20110407/Roche-LightCycler-480-PCR-System-to-be-used-at-Koch-Institute-for-advanced-cancer-research.aspx. (accessed December 05, 2020).

  • Harvard

    Roche Diagnostics Limited. 2019. Roche LightCycler 480 PCR System to be used at Koch Institute for advanced cancer research. News-Medical, viewed 05 December 2020, https://www.news-medical.net/news/20110407/Roche-LightCycler-480-PCR-System-to-be-used-at-Koch-Institute-for-advanced-cancer-research.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Roche launches the cobas EGFR Mutation Test v2 for use with either plasma or tumour tissue samples